Published in Int J Cell Biol on December 30, 2009
In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2015) 1.40
Bone morphogenetic protein signaling suppresses wound-induced skin repair by inhibiting keratinocyte proliferation and migration. J Invest Dermatol (2013) 0.89
Necessity of Smad4 for the normal development of the mouse lacrimal gland. Jpn J Ophthalmol (2014) 0.76
Skin as a living coloring book: how epithelial cells create patterns of pigmentation. Pigment Cell Melanoma Res (2014) 0.75
Vitis amurensis Ruprecht root inhibited α-melanocyte stimulating hormone-induced melanogenesis in B16F10 cells. Nutr Res Pract (2014) 0.75
Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94
Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev (2004) 5.89
Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature (1996) 5.21
The cloning of a family of genes that encode the melanocortin receptors. Science (1992) 4.64
A human Mad protein acting as a BMP-regulated transcriptional activator. Nature (1996) 4.36
Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron (2000) 4.18
MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell (1996) 3.87
Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet (2004) 3.78
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell (2002) 3.72
MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature (1998) 3.53
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem (1994) 3.49
The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev (1997) 3.28
c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev (2000) 3.13
Signal transduction of bone morphogenetic protein receptors. Cell Signal (2004) 3.11
Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol (1995) 2.80
Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev (1998) 2.56
Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res (2002) 2.48
Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev (2000) 2.43
A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. Proc Natl Acad Sci U S A (1994) 2.40
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A (1995) 2.19
Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol (1994) 2.16
MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol (2003) 1.90
ERK signaling is a central regulator for BMP-4 dependent capillary sprouting. Cardiovasc Res (2007) 1.90
Human melanogenesis is stimulated by diacylglycerol. J Invest Dermatol (1989) 1.71
Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. J Biol Chem (1997) 1.59
Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor. J Biol Chem (1995) 1.57
Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res (2000) 1.53
Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology (1996) 1.52
Topically applied diacylglycerols increase pigmentation in guinea pig skin. J Invest Dermatol (1995) 1.52
Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem (1992) 1.51
Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Opin Cell Biol (1996) 1.50
Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia. J Biol Chem (1998) 1.47
Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem (1995) 1.47
The transcription network regulating melanocyte development and melanoma. Pigment Cell Res (2004) 1.42
Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci U S A (1995) 1.42
Genomic analysis of the Microphthalmia locus and identification of the MITF-J/Mitf-J isoform. Gene (2005) 1.35
Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J Investig Dermatol Symp Proc (2001) 1.29
Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol (1991) 1.26
Wnt and BMP signaling govern lineage segregation of melanocytes in the avian embryo. Dev Biol (2001) 1.25
Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene. Biochem Biophys Res Commun (1996) 1.24
Microphthalmia-associated transcription factor regulates RAB27A gene expression and controls melanosome transport. J Biol Chem (2008) 1.22
Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am J Pathol (1991) 1.20
Tyrosinase as a marker for transgenic mice. Nucleic Acids Res (1991) 1.14
Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol (1995) 1.12
MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes. Biochem J (2006) 1.11
Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway. Proc Natl Acad Sci U S A (2004) 1.10
Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation. Int J Biochem Cell Biol (2004) 1.07
Transforming growth factor-beta1 inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1. J Biol Chem (1997) 1.00
Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci (2002) 0.97
Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J Biol Chem (1999) 0.97
The beta isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J Biol Chem (1993) 0.97
Proopiomelanocortin gene product regulation in keratinocytes. J Invest Dermatol (1996) 0.97
Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage. Melanoma Res (2002) 0.94
Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. J Invest Dermatol (2004) 0.92
A phosphodiesterase inhibitor, pentoxifylline, enhances the bone morphogenetic protein-4 (BMP-4)-dependent differentiation of osteoprogenitor cells. Bone (2002) 0.88
Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation? Melanoma Res (2001) 0.87
Production of the soluble form of KIT, s-KIT, abolishes stem cell factor-induced melanogenesis in human melanocytes. J Invest Dermatol (2008) 0.87
Acute hyperglycemia regulates transcription and posttranscriptional stability of PKCbetaII mRNA in vascular smooth muscle cells. FASEB J (1999) 0.86
Cloning and characterization of the major promoter of the human protein kinase C beta gene. Regulation by phorbol esters. J Biol Chem (1992) 0.86
Involvement of phosphodiesterase isozymes in osteoblastic differentiation. J Bone Miner Res (2002) 0.85
Hormonal control of melanocytes: MSH-sensitive adenyl cyclase in the Cloudman melanoma. Yale J Biol Med (1973) 0.85
The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes. J Cell Sci (2004) 0.84
Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C. Exp Cell Res (1996) 0.84
Bone morphogenetic protein-4, a novel modulator of melanogenesis. J Biol Chem (2006) 0.83
Enhancement of aldosterone-induced catecholamine production by bone morphogenetic protein-4 through activating Rho and SAPK/JNK pathway in adrenomedullar cells. Am J Physiol Endocrinol Metab (2009) 0.78
Stimulation of tyrosinase in human melanocytes by pro-opiomelanocortin-derived peptides. J Endocrinol (1995) 0.76
A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol (2006) 2.29
Academic dermatology manpower: issues of recruitment and retention. Arch Dermatol (2007) 2.02
Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation. Circ Heart Fail (2012) 1.79
Melanoma incidence and mortality among US whites, 1969-1999. JAMA (2002) 1.74
Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol (2005) 1.68
The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol (2006) 1.66
Ultraviolet-fluorescent tattoo location of cutaneous biopsy site. Dermatol Surg (2011) 1.51
Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol (2007) 1.41
Pitfalls of evidence-based medicine: the example of actinic keratosis therapy. Arch Dermatol (2012) 1.40
THE BIOLOGIC BASIS OF TRANSGENDER IDENTITY: 2D:4D FINGER LENGTH RATIOS IMPLICATE A ROLE FOR PRENATAL ANDROGEN ACTIVITY. Endocr Pract (2017) 1.39
Evidence that exposure of the telomere 3' overhang sequence induces senescence. Proc Natl Acad Sci U S A (2003) 1.37
Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene (2002) 1.37
Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J (2003) 1.27
Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas. Ann Surg Oncol (2014) 1.25
Modulation of BMP signaling by noggin is required for induction of the secondary (nontylotrich) hair follicles. J Invest Dermatol (2002) 1.25
Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem (2001) 1.23
Skin cancer prevention and detection practices among siblings of patients with melanoma. J Am Acad Dermatol (2003) 1.22
Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. FASEB J (2007) 1.22
Telomere-based DNA damage responses: a new approach to melanoma. FASEB J (2004) 1.21
Single-incision laparoscopic versus conventional laparoscopic right hemicolectomy: a comparison of short-term surgical results. Surg Endosc (2011) 1.17
p75 Neurotrophin receptor antagonist retards apoptosis-driven hair follicle involution (catagen). J Invest Dermatol (2003) 1.16
A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol (2004) 1.14
Improving skin cancer prevention and detection education in US medical schools. Arch Dermatol (2006) 1.14
Induction of apoptosis by telomere 3' overhang-specific DNA. Exp Cell Res (2002) 1.14
Unity in action. J Invest Dermatol (2014) 1.12
MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes. Biochem J (2006) 1.11
Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway. Proc Natl Acad Sci U S A (2004) 1.10
Fifty years of skin aging. J Investig Dermatol Symp Proc (2002) 1.10
Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. Int J Cancer (2009) 1.08
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res (2007) 1.06
A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer (2006) 1.05
Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. Exp Cell Res (2004) 1.05
Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation. Am J Cardiol (2013) 1.04
Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice. Proc Natl Acad Sci U S A (2004) 1.04
Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA. FASEB J (2003) 1.04
A role for WRN in telomere-based DNA damage responses. Proc Natl Acad Sci U S A (2006) 1.03
Recent therapeutic advances in the treatment of colorectal cancer. Annu Rev Med (2014) 1.03
A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions. J Transl Med (2011) 1.00
The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol (2003) 1.00
Fate of melanocytes during development of the hair follicle pigmentary unit. J Investig Dermatol Symp Proc (2003) 0.97
Neurotrophins in skin biology and pathology. J Invest Dermatol (2006) 0.97
delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg (2004) 0.97
T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter. J Biol Chem (2005) 0.96
Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells. J Cell Physiol (2007) 0.93
DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacity. FASEB J (2002) 0.92
Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. J Invest Dermatol (2004) 0.92
Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- mice. Am J Pathol (2008) 0.92
Psychosocial aspects of aging skin. Dermatol Clin (2005) 0.91
The year of unity. J Invest Dermatol (2013) 0.90
Quantification of inducible SOS-like photoprotective responses in human skin. J Invest Dermatol (2007) 0.89
Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol (2007) 0.89
Telomere-mediated effects on melanogenesis and skin aging. J Investig Dermatol Symp Proc (2009) 0.87
T-oligos augment UV-induced protective responses in human skin. FASEB J (2006) 0.86
The interdependence of skin aging, skin cancer, and DNA repair capacity: a novel perspective with therapeutic implications. Rejuvenation Res (2004) 0.85
Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage. J Dermatol Sci (2009) 0.85
Fas signaling is involved in the control of hair follicle response to chemotherapy. Cancer Res (2004) 0.85
Tyrosinase gene expression is regulated by p53. J Invest Dermatol (2002) 0.85
Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure. J Cachexia Sarcopenia Muscle (2014) 0.84
The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes. J Cell Sci (2004) 0.84
Modulation of vascular endothelial growth factor receptors in melanocytes. Exp Dermatol (2005) 0.84
Modulations of nerve growth factor and Bcl-2 in ultraviolet-irradiated human epidermis. J Cutan Pathol (2003) 0.84
Bone morphogenetic protein-4, a novel modulator of melanogenesis. J Biol Chem (2006) 0.83
Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss. J Invest Dermatol (2003) 0.83
Should the skin cancer examination be taught in medical school? Arch Dermatol (2002) 0.83
UV induces VEGF through a TNF-alpha independent pathway. FASEB J (2003) 0.82
More on MITF. J Invest Dermatol (2002) 0.82
Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome. J Drugs Dermatol (2006) 0.82
Inhibition of melanoma angiogenesis by telomere homolog oligonucleotides. J Oncol (2010) 0.81
Photoprotection in human skin--a multifaceted SOS response. Photochem Photobiol (2008) 0.81
Topical application of thymidine dinucleotide to newborn mice reduces and delays development of UV-induced melanomas. J Invest Dermatol (2012) 0.81
Inhibition of the elicitation phase of contact hypersensitivity by thymidine dinucleotides is in part mediated by increased expression of interleukin-10 in human keratinocytes. Exp Dermatol (2003) 0.81
Skin cancer examination teaching in US medical education. Arch Dermatol (2006) 0.81
Laparoscopic excision is an alterative method for rectal gastrointestinal stromal tumor. Surg Laparosc Endosc Percutan Tech (2010) 0.81
Oligonucleotide treatment increases eumelanogenesis, hair pigmentation and melanocortin-1 receptor expression in the hair follicle. Exp Dermatol (2007) 0.80
What is all this commotion about vitamin D? J Invest Dermatol (2010) 0.79
Topical photodynamic therapy: a new tool in cosmetic dermatology. Semin Cutan Med Surg (2003) 0.79
Keratin 16 expression in epidermal melanocytes of normal human skin. Am J Dermatopathol (2005) 0.79
Detection of UV-induced pigmentary and epidermal changes over time using in vivo reflectance confocal microscopy. J Invest Dermatol (2006) 0.79
Photodynamic therapy for treatment of hand warts. Dermatol Surg (2012) 0.78
What is the optimal neo-adjuvant treatment for liver metastasis? Ther Adv Med Oncol (2013) 0.78
What you and your patients need to know about vitamin D. Semin Cutan Med Surg (2012) 0.78
Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment. Breast Cancer Res (2010) 0.78
p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation. Cell Mol Neurobiol (2008) 0.77
Melanocyte biology: before, during, and after the Fitzpatrick era. J Invest Dermatol (2004) 0.77
Solar-simulated irradiation evokes a persistent and biphasic IL-1alpha response. Exp Dermatol (2004) 0.77
Effect of sunscreen application on UV-induced thymine dimers. Arch Dermatol (2002) 0.77